Landec Corporation Reports Second Quarter and First Half Fiscal Year 2021 Results
Landec Corporation (Nasdaq: LNDC) reported fiscal Q2 2021 results, featuring revenues of $130.9 million, down 8.2% year-over-year, while gross profit increased 33% to $20.6 million. The net loss was $13.3 million, impacted by restructuring charges and fair market value adjustments. Adjusted EBITDA rose significantly to $8.7 million, compared to $0.9 million in the prior year. Curation Foods segment showed improvement, with gross margin increasing to 9.4%. The company reiterated its fiscal 2021 guidance, projecting revenues of $530-$550 million. A refinancing of credit facilities was completed, enhancing financial flexibility.
- Adjusted EBITDA increased 882% year-over-year to $8.7 million.
- Curation Foods gross margin improved approximately 360 basis points to 9.4%.
- Total cash flow from operations improved by $33.4 million year-over-year to $18.5 million.
- Net loss increased to $13.3 million from $6.7 million in the prior year period.
- Consolidated revenues decreased by 8.2% compared to the previous year.
- Curation Foods segment revenues dropped 10% due to legacy business reductions.
Reiterates Fiscal 2021 Guidance
SANTA MARIA, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., reported results for the fiscal 2021 second quarter and year-to-date period ended November 29, 2020. Looking forward, Landec’s strategy to create shareholder value is to deliver against its long-term targets, strengthen its balance sheet, selectively invest in innovation and growth and implement strategic priorities to improve operating margins at Curation Foods and drive top line growth at Lifecore.
CEO COMMENTS:
Dr. Albert Bolles, Landec’s President and CEO stated, “We are delivering against our strategic plan to create shareholder value by significantly improving the performance of Curation Foods in the first six months of fiscal 2021, supporting the growth of Lifecore, and implementing a comprehensive refinancing of the balance sheet. We drove a
Dr. Bolles continued, “At Lifecore, we remain focused on supporting its business development pipeline and advancing commercialization of key projects to drive consistent long-term double-digit growth in a robust CDMO marketplace. At Curation Foods, we believe that we have right sized and focused the business and are beginning to demonstrate significant measurable improvements. This is perhaps most visible in Curation Foods’ gross margin profile, which increased approximately 360 basis points to
FISCAL SECOND QUARTER 2021 BUSINESS HIGHLIGHTS:
- Revenues of
$130.9 million , a planned decrease of8.2% year-over-year - Gross profit of
$20.6 million , an increase of33.0% year-over-year - Net loss of
$13.3 million , which includes$4.4 million of restructuring and other non-recurring charges such as legal expenses, as well as a Windset non-cash fair market value adjustment of$9.4 million , both net of tax - Diluted net loss per share of
$0.45 ; adjusted diluted net income per share of$0.02 , which excludes$0.15 per share of restructuring and other non-recurring charges, as well as a$0.32 per share negative Windset fair market value adjustment, both net of tax - Adjusted EBITDA of
$8.7 million , compared to$0.9 million in the prior year period - Lifecore segment adjusted EBITDA of
$7.3 million , compared to$5.6 million in the prior year period - Curation Foods segment adjusted EBITDA of
$2.4 million , compared to a loss of$4.4 million in the prior year period - Closed on a comprehensive refinancing of credit facilities, which was subsequently completed on December 31, 2020
FIRST SIX MONTHS FISCAL 2021 BUSINESS HIGHLIGHTS:
- Revenues of
$266.5 million , a planned decrease of5.2% year-over-year - Gross profit of
$37.0 million , an increase of19.9% year-over-year - Net loss of
$24.3 million , which includes$12.5 million of restructuring and other non-recurring charges such as expenses incurred by consolidating and optimizing operations associated with Project SWIFT, as well as a Windset non-cash fair market value adjustment of$9.1 million , both net of tax - Diluted net loss per share of
$0.83 ; adjusted diluted net loss per share of$0.09 , which excludes$0.43 per share of restructuring and other non-recurring charges, as well as a$0.31 per share negative Windset fair market value adjustment, both net of tax - Adjusted EBITDA of
$11.8 million , compared to$1.2 million in the prior year period - Lifecore segment adjusted EBITDA of
$8.7 million , compared to$5.0 million in the prior year period - Curation Foods segment adjusted EBITDA of
$4.7 million , compared to a loss of$2.6 million in the prior year period - Cash flow provided by operations was
$18.5 million , an improvement of$33.4 million year-over-year
SECOND QUARTER 2021 RESULTS:
Fiscal second quarter 2021 results compared to fiscal second quarter 2020 are as follows:
(Unaudited and in thousands, except per-share data) | Three Months Ended | Change | |||||||||||||||||
November 29, 2020 | November 24, 2019 | Amount | % | ||||||||||||||||
Revenues | $ | 130,904 | $ | 142,593 | $ | (11,689 | ) | (8 | ) | % | |||||||||
Gross profit | 20,637 | 15,514 | 5,123 | 33 | % | ||||||||||||||
Net loss | (13,301 | ) | (6,740 | ) | (6,561 | ) | (97 | ) | % | ||||||||||
Adjusted net income (loss) | 506 | (4,835 | ) | 5,341 | N/M | ||||||||||||||
Diluted net loss per share | (0.45 | ) | (0.23 | ) | (0.22 | ) | (96 | ) | % | ||||||||||
Adjusted diluted net income (loss) per share* | 0.02 | (0.17 | ) | 0.19 | N/M | ||||||||||||||
EBITDA* | 3,120 | (1,547 | ) | 4,667 | N/M | ||||||||||||||
Adjusted EBITDA* | $ | 8,710 | $ | 887 | $ | 7,823 | 882 | % |
* See “Non-GAAP Financial Information” at the end of this release for more information and for a reconciliation of certain financial information.
Revenues decreased
Gross profit increased
Net loss increased
Adjusted EBITDA increased
SEGMENT RESULTS:
(Unaudited and in thousands) | Three Months Ended | Change | Six Months Ended | Change | ||||||||||||||||||||||||||||||||||
November 29, 2020 | November 24, 2019 | Amount | % | November 29, 2020 | November 24, 2019 | Amount | % | |||||||||||||||||||||||||||||||
Revenues: | ||||||||||||||||||||||||||||||||||||||
Curation Foods | $ | 107,685 | $ | 119,751 | $ | (12,066 | ) | (10 | ) | % | $ | 221,523 | $ | 246,424 | $ | (24,901 | ) | (10 | ) | % | ||||||||||||||||||
Lifecore | 23,219 | 22,842 | 377 | 2 | % | 45,024 | 34,883 | 10,141 | 29 | % | ||||||||||||||||||||||||||||
Total revenues | $ | 130,904 | $ | 142,593 | $ | (11,689 | ) | (8 | ) | % | $ | 266,547 | $ | 281,307 | $ | (14,760 | ) | (5 | ) | % | ||||||||||||||||||
Gross profit: | ||||||||||||||||||||||||||||||||||||||
Curation Foods | $ | 10,163 | $ | 6,890 | $ | 3,273 | 48 | % | $ | 21,507 | $ | 19,712 | $ | 1,795 | 9 | % | ||||||||||||||||||||||
Lifecore | 10,474 | 8,624 | 1,850 | 21 | % | 15,476 | 11,138 | 4,338 | 39 | % | ||||||||||||||||||||||||||||
Total gross profit | $ | 20,637 | $ | 15,514 | $ | 5,123 | 33 | % | $ | 36,983 | $ | 30,850 | $ | 6,133 | 20 | % | ||||||||||||||||||||||
Net (loss) income: | ||||||||||||||||||||||||||||||||||||||
Curation Foods | $ | (12,383 | ) | $ | (8,348 | ) | $ | (4,035 | ) | (48 | ) | % | $ | (20,654 | ) | $ | (10,519 | ) | $ | (10,135 | ) | (96 | ) | % | ||||||||||||||
Lifecore | 4,492 | 3,459 | 1,033 | 30 | % | 4,604 | 2,064 | 2,540 | 123 | % | ||||||||||||||||||||||||||||
Corporate | (5,410 | ) | (1,851 | ) | (3,559 | ) | (192 | ) | % | (8,251 | ) | (3,069 | ) | (5,182 | ) | (169 | ) | % | ||||||||||||||||||||
Total net loss | $ | (13,301 | ) | $ | (6,740 | ) | $ | (6,561 | ) | (97 | ) | % | $ | (24,301 | ) | $ | (11,524 | ) | $ | (12,777 | ) | (111 | ) | % | ||||||||||||||
EBITDA: | ||||||||||||||||||||||||||||||||||||||
Curation Foods | $ | (212 | ) | $ | (5,764 | ) | $ | 5,552 | 96 | % | $ | (6,310 | ) | $ | (3,960 | ) | $ | (2,350 | ) | (59 | ) | % | ||||||||||||||||
Lifecore | 7,271 | 5,626 | 1,645 | 29 | % | 8,727 | 4,951 | 3,776 | 76 | % | ||||||||||||||||||||||||||||
Corporate | (3,938 | ) | (1,409 | ) | (2,529 | ) | (179 | ) | % | (6,759 | ) | (2,224 | ) | (4,535 | ) | (204 | ) | % | ||||||||||||||||||||
Total EBITDA | $ | 3,121 | $ | (1,547 | ) | $ | 4,668 | N/M | $ | (4,342 | ) | $ | (1,233 | ) | $ | (3,109 | ) | (252 | ) | % |
Lifecore Segment:
(Unaudited and in thousands) | Three Months Ended | Change | Six Months Ended | Change | ||||||||||||||||||||||||||||||||||
November 29, 2020 | November 24, 2019 | Amount | % | November 29, 2020 | November 24, 2019 | Amount | % | |||||||||||||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||||||||||||||||
CDMO | $ | 18,259 | $ | 17,810 | $ | 449 | 3 | % | $ | 34,747 | $ | 29,113 | $ | 5,634 | 19 | % | ||||||||||||||||||||||
Fermentation | 4,960 | 5,032 | (72 | ) | (1 | ) | % | 10,277 | 5,770 | 4,507 | 78 | % | ||||||||||||||||||||||||||
Total revenue | $ | 23,219 | $ | 22,842 | $ | 377 | 2 | % | $ | 45,024 | $ | 34,883 | $ | 10,141 | 29 | % |
Lifecore is the Company’s CDMO business focused on product development and manufacturing of sterile injectable products. Lifecore continues to expand its presence in the robust CDMO marketplace by finding additional opportunities to partner with and provide value added services to biopharmaceutical and medical device companies. Lifecore continues to drive growth and profitability with a focus on building its business development pipeline, maximizing capacity and advancing product commercialization for innovative new therapies that improve patients’ lives.
In the second quarter, Lifecore realized total revenues of
Curation Foods Segment:
(Unaudited and in thousands) | Three Months Ended | Change | Six Months Ended | Change | ||||||||||||||||||||||||||||||||||
November 29, 2020 | November 24, 2019 | Amount | % | November 29, 2020 | November 24, 2019 | Amount | % | |||||||||||||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||||||||||||||||
Fresh packaged salads and vegetables | $ | 92,423 | $ | 104,912 | $ | (12,489 | ) | (12 | ) | % | $ | 188,602 | $ | 214,743 | $ | (26,141 | ) | (12 | ) | % | ||||||||||||||||||
Avocado products | 14,713 | 14,021 | 692 | 5 | % | 31,729 | 30,221 | 1,508 | 5 | % | ||||||||||||||||||||||||||||
Technology | 549 | 818 | (269 | ) | (33 | ) | % | 1,192 | 1,460 | (268 | ) | (18 | ) | % | ||||||||||||||||||||||||
Total revenue | $ | 107,685 | $ | 119,751 | $ | (12,066 | ) | (10 | ) | % | $ | 221,523 | $ | 246,424 | $ | (24,901 | ) | (10 | ) | % |
Curation Foods is the Company’s natural food business. Curation Foods is focused on providing access to innovative and nutritious
Curation Foods realized total revenues of
CASH FLOW & BALANCE SHEET
Cash provided by operations was
The Company had cash and cash equivalents of
Subsequent Comprehensive Refinancing of Credit Facilities:
On January 4, 2020, the Company announced its entry into a
The
The
As a result of refinancing the Company’s existing credit facilities with these new credit facilities, in the third quarter of fiscal 2021, Landec expects to record a
FISCAL 2021 OUTLOOK:
Excluding restructuring and other nonrecurring charges, tax implications and any potential impact from the ongoing COVID-19 pandemic, the Company is reiterating its full year fiscal 2021 guidance, which is detailed below with growth figures that are compared to fiscal 2020.
Revenue from continuing operations:
- Consolidated Revenues: range of
$530 million to$550 million (-10% to -7% ) - Lifecore: range of
$93 million to$97 million (+8% to +13% ) - Curation Foods: range of
$437 million to$453 million (-13% to -10% )
Adjusted EBITDA:
- Consolidated: range of
$33 million to$37 million (+50% to +68% ) - Lifecore: range of
$22.5 million to$24.5 million (+12% to +22% ) - Curation Foods: range of
$12 million to$14 million (+181% to +238% )
Seasonality:
- Revenue: The Company anticipates that fiscal third quarter revenue will be greater than the fiscal fourth quarter revenue for both operating segments due to variations in seasonality.
- Gross margin: The Company believes that Curation Foods will continue to generate consistent sequential quarterly improvement in its gross profit margin as the business builds towards its steady-state gross profit margin target of
11% to14% by fiscal year-end 2021. The Company believes that Lifecore has reverted to its pre-COVID gross margin levels and is managing the business to its annualized target of approximately40% . Taking into account its fiscal first quarter COVID-related margin impact, the Company expects Lifecore to achieve full year fiscal 2021 gross margin of approximately38% . - Adjusted EBITDA: The Company continues to anticipate minimal quarterly variation between fiscal third and fiscal fourth quarter for its consolidated adjusted EBITDA results.
Conference Call
The live webcast can be accessed directly at http://ir.Landec.com/events.cfm or on Landec’s website on the Investor Events & Presentations page. The webcast will be available for 30 days.
Date: Wednesday, January 6, 2021
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Direct Webcast link: http://ir.Landec.com/events.cfm
To participate in the conference call via telephone, dial toll-free: (877) 407-3982 or (201) 493-6780. Please call the conference telephone number 5-10 minutes prior to the start time so the operator can register your name and organization. If you have any difficulty with the webcast or connecting to the call, please contact ICR at (646) 277-1263.
A replay of the call will be available through Wednesday, January 13, 2021 by calling toll-free: (844) 512-2921 or direct (412) 317-6671, and entering code 13714051.
About Landec Corporation
Landec Corporation (NASDAQ: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc. Landec designs, develops, manufactures, and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with
Non-GAAP Financial Information
This press release contains non-GAAP financial information relating to EBITDA, adjusted EBITDA, and adjusted net income or (loss) per share. The Company has included reconciliations of these non-GAAP financial measures to their respective most directly comparable financial measures calculated in accordance with GAAP. See the section entitled “Non-GAAP Financial Information and Reconciliations” in this release for definitions of EBITDA, adjusted EBITDA, and adjusted net income or (loss) per share, and those reconciliations.
The Company has disclosed these non-GAAP financial measures to supplement its consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures exclude/include certain items that are included in the Company’s results reported in accordance with GAAP. Management believes these non-GAAP financial measures provide useful additional information to investors about trends in the Company’s operations and are useful for period-over-period comparisons. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be the same as similar measures provided by other companies due to the potential differences in methods of calculation and items being excluded/included. These non-GAAP financial measures should be read in conjunction with the Company’s consolidated financial statements presented in accordance with GAAP.
Important Cautions Regarding Forward-Looking Statements
This press release contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange Act of 1934. Words such as “anticipate”, “estimate”, “expect”, “project”, “plan”, “intend”, “believe”, “may”, “might”, “will”, “should”, “can have”, “likely” and similar expressions are used to identify forward-looking statements. All forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially, including such factors among others, as the timing and expenses associated with operations, the ability to achieve acceptance of the Company’s new products in the market place, weather conditions that can affect the supply and price of produce, government regulations affecting our business, the timing of regulatory approvals, uncertainties related to COVID-19 and the impact of our responses to it, the ability to successfully integrate Yucatan Foods into the Curation Foods business, and the mix between domestic and international sales. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the Securities and Exchange Commission, including the risk factors contained in our most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K. Forward-looking statements represent management’s current expectations and are inherently uncertain. Except as required by law, we do not undertake any obligation to update forward-looking statements made by us to reflect subsequent events or circumstances.
LANDEC CORPORATION
CONSOLIDATED CONDENSED BALANCE SHEETS
(In thousands, except par value)
November 29, 2020 | May 31, 2020 | ||||||||
(Unaudited) | |||||||||
ASSETS | |||||||||
Current Assets: | |||||||||
Cash and cash equivalents | $ | 2,491 | $ | 360 | |||||
Accounts receivable, less allowance for credit losses | 66,545 | 76,206 | |||||||
Inventories | 71,202 | 66,311 | |||||||
Prepaid expenses and other current assets | 13,949 | 14,230 | |||||||
Total Current Assets | 154,187 | 157,107 | |||||||
Investment in non-public company, fair value | 45,100 | 56,900 | |||||||
Property and equipment, net | 170,973 | 192,338 | |||||||
Operating leases | 21,070 | 25,321 | |||||||
Goodwill | 69,386 | 69,386 | |||||||
Trademarks/tradenames, net | 25,328 | 25,328 | |||||||
Customer relationships, net | 11,784 | 12,777 | |||||||
Other assets | 1,332 | 2,156 | |||||||
Total Assets | $ | 499,160 | $ | 541,313 | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||
Current Liabilities: | |||||||||
Accounts payable | $ | 60,892 | $ | 51,647 | |||||
Accrued compensation | 7,689 | 9,034 | |||||||
Other accrued liabilities | 12,715 | 9,978 | |||||||
Current portion of lease liabilities | 3,785 | 4,423 | |||||||
Deferred revenue | 644 | 352 | |||||||
Line of credit | 77,000 | 77,400 | |||||||
Current portion of long-term debt, net | 11,189 | 11,554 | |||||||
Total Current Liabilities | 173,914 | 164,388 | |||||||
Long-term debt, net | 82,000 | 101,363 | |||||||
Long-term lease liabilities | 22,206 | 26,378 | |||||||
Deferred taxes, net | 6,745 | 13,588 | |||||||
Other non-current liabilities | 5,357 | 4,552 | |||||||
Total Liabilities | 290,222 | 310,269 | |||||||
Stockholders’ Equity: | |||||||||
Common stock, | 29 | 29 | |||||||
Additional paid-in capital | 164,068 | 162,578 | |||||||
Retained earnings | 46,944 | 71,245 | |||||||
Accumulated other comprehensive (loss) income | (2,103 | ) | (2,808 | ) | |||||
Total Stockholders’ Equity | 208,938 | 231,044 | |||||||
Total Liabilities and Stockholders’ Equity | $ | 499,160 | $ | 541,313 |
LANDEC CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(Unaudited)
(In thousands, except per share amounts)
Three Months Ended | Six Months Ended | ||||||||||||||||||
November 29, 2020 | November 24, 2019 | November 29, 2020 | November 24, 2019 | ||||||||||||||||
Product sales | $ | 130,904 | $ | 142,593 | $ | 266,547 | $ | 281,307 | |||||||||||
Cost of product sales | 110,267 | 127,079 | 229,564 | 250,457 | |||||||||||||||
Gross profit | 20,637 | 15,514 | 36,983 | 30,850 | |||||||||||||||
Operating costs and expenses: | |||||||||||||||||||
Research and development | 2,572 | 2,822 | 5,080 | 5,643 | |||||||||||||||
Selling, general and administrative | 16,106 | 18,728 | 34,009 | 35,623 | |||||||||||||||
Legal settlement charge | 1,763 | — | 1,763 | — | |||||||||||||||
Restructuring costs | 1,662 | — | 10,066 | — | |||||||||||||||
Total operating costs and expenses | 22,103 | 21,550 | 50,918 | 41,266 | |||||||||||||||
Operating loss | (1,466 | ) | (6,036 | ) | (13,935 | ) | (10,416 | ) | |||||||||||
Dividend income | 281 | 281 | 563 | 562 | |||||||||||||||
Interest income | 10 | 25 | 18 | 50 | |||||||||||||||
Interest expense, net | (3,039 | ) | (2,169 | ) | (6,148 | ) | (4,244 | ) | |||||||||||
Other (expense) income, net | (11,787 | ) | (6 | ) | (11,808 | ) | (6 | ) | |||||||||||
Net loss before tax | (16,001 | ) | (7,905 | ) | (31,310 | ) | (14,054 | ) | |||||||||||
Income tax benefit | 2,700 | 1,165 | 7,009 | 2,530 | |||||||||||||||
Net loss | $ | (13,301 | ) | $ | (6,740 | ) | $ | (24,301 | ) | $ | (11,524 | ) | |||||||
Diluted net loss per common share | $ | (0.45 | ) | $ | (0.23 | ) | $ | (0.83 | ) | $ | (0.40 | ) | |||||||
Shares used in diluted per share computation | 29,280 | 29,155 | 29,261 | 29,147 |
LANDEC CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
Six Months Ended | |||||||||
November 29, 2020 | November 24, 2019 | ||||||||
Cash flows from operating activities: | |||||||||
Consolidated net loss | $ | (24,301 | ) | $ | (11,524 | ) | |||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||||
Depreciation, amortization of intangibles and amortization of debt costs | 9,826 | 9,030 | |||||||
Stock-based compensation expense | 1,787 | 1,315 | |||||||
Deferred taxes | (7,070 | ) | (2,624 | ) | |||||
Change in investment in non-public company, fair value | 11,800 | (200 | ) | ||||||
Net gain on disposal of property and equipment held and used | (34 | ) | (15 | ) | |||||
Loss on disposal of property and equipment related to restructuring, net | 6,005 | 406 | |||||||
Other, net | 21 | 206 | |||||||
Change in contingent consideration liability | — | (500 | ) | ||||||
Pacific Harvest note receivable reserve | — | 1,202 | |||||||
Changes in current assets and current liabilities: | |||||||||
Accounts receivable, net | 9,661 | (397 | ) | ||||||
Inventories | (4,891 | ) | (4,431 | ) | |||||
Prepaid expenses and other current assets | 1,539 | (554 | ) | ||||||
Accounts payable | 10,539 | (6,105 | ) | ||||||
Accrued compensation | (1,345 | ) | (1,988 | ) | |||||
Other accrued liabilities | 4,627 | 1,145 | |||||||
Deferred revenue | 292 | 112 | |||||||
Net cash provided by (used in) operating activities | 18,456 | (14,922 | ) | ||||||
Cash flows from investing activities: | |||||||||
Proceeds from sales of fixed assets | 12,885 | 29 | |||||||
Purchases of property and equipment | (7,407 | ) | (16,029 | ) | |||||
Proceeds from collections of notes receivable | — | 364 | |||||||
Net cash provided by (used in) investing activities | 5,478 | (15,636 | ) | ||||||
Cash flows from financing activities: | |||||||||
Taxes paid by Company for employee stock plans | (297 | ) | (130 | ) | |||||
Payments on long-term debt | (20,062 | ) | (5,062 | ) | |||||
Proceeds from lines of credit | 24,000 | 62,900 | |||||||
Payments on lines of credit | (24,400 | ) | (53,400 | ) | |||||
Payments for debt issuance costs | (1,237 | ) | (766 | ) | |||||
Proceeds from sale of common stock | — | 30 | |||||||
Proceeds from long-term debt | — | 27,500 | |||||||
Net cash (used in) provided by financing activities | (21,996 | ) | 31,072 | ||||||
Net decrease in cash, cash equivalents and restricted cash | 1,938 | 514 | |||||||
Cash and cash equivalents, beginning of period | 553 | 1,465 | |||||||
Cash and cash equivalents, end of period | $ | 2,491 | $ | 1,979 | |||||
Supplemental disclosure of non-cash investing and financing activities: | |||||||||
Purchases of property and equipment on trade vendor credit | $ | 1,526 | $ | 3,174 |
Non-GAAP Financial Information and Reconciliations
EBITDA, adjusted EBITDA, adjusted net income (loss), and adjusted diluted net income (loss) per share are non-GAAP financial measures. We define EBITDA as earnings before the fair market value change of the Company’s investment in Windset, interest expense, income tax expense (benefit), and depreciation and amortization. We define adjusted EBITDA as EBITDA before certain restructuring and other non-recurring charges and before impairment of goodwill and intangibles charges. We define adjusted net income (loss) and adjusted diluted net income (loss) per share as net income (loss) and diluted net income (loss) per share, respectively, before certain restructuring and other non-recurring charges and before the fair market value change of the Company’s investment in Windset, net of tax, and before impairment of goodwill and intangibles charges, net of tax. The table below presents the reconciliation of these non-GAAP financial measures to their respective most directly comparable financial measures calculated in accordance with GAAP and other supplemental information. See “Non-GAAP Financial Information” above for further information regarding the Company’s use of non-GAAP financial measures.
(Unaudited and in thousands) | Three Months Ended | Six Months Ended | ||||||||||||||||||
November 29, 2020 | November 24, 2019 | November 29, 2020 | November 24, 2019 | |||||||||||||||||
Net loss | $ | (13,301 | ) | $ | (6,740 | ) | $ | (24,301 | ) | $ | (11,524 | ) | ||||||||
FMV change in Windset investment | 11,800 | (200 | ) | 11,800 | (200 | ) | ||||||||||||||
Interest expense, net of interest income | 3,029 | 2,144 | 6,130 | 4,194 | ||||||||||||||||
Income tax benefit | (2,700 | ) | (1,165 | ) | (7,009 | ) | (2,530 | ) | ||||||||||||
Depreciation and amortization | 4,292 | 4,414 | 9,039 | 8,827 | ||||||||||||||||
Total EBITDA | 3,120 | (1,547 | ) | (4,341 | ) | (1,233 | ) | |||||||||||||
Restructuring and other non-recurring charges (1) | 5,590 | 2,434 | 16,161 | 2,434 | ||||||||||||||||
Total adjusted EBITDA | $ | 8,710 | $ | 887 | $ | 11,820 | $ | 1,201 |
(Unaudited and in thousands) | Three Months Ended | Six Months Ended | ||||||||||||||||||
November 29, 2020 | November 24, 2019 | November 29, 2020 | November 24, 2019 | |||||||||||||||||
Net loss | $ | (13,301 | ) | $ | (6,740 | ) | $ | (24,301 | ) | $ | (11,524 | ) | ||||||||
FMV change in Windset investment, net of tax | 9,369 | (171 | ) | 9,121 | (164 | ) | ||||||||||||||
Restructuring and other non-recurring charges, net of tax (1) | 4,438 | 2,076 | 12,492 | 1,996 | ||||||||||||||||
Adjusted net income (loss) | $ | 506 | $ | (4,835 | ) | $ | (2,688 | ) | $ | (9,692 | ) |
(Unaudited) | Three Months Ended | Six Months Ended | ||||||||||||||||||
November 29, 2020 | November 24, 2019 | November 29, 2020 | November 24, 2019 | |||||||||||||||||
Diluted net loss per share | $ | (0.45 | ) | $ | (0.23 | ) | $ | (0.83 | ) | $ | (0.40 | ) | ||||||||
FMV change in Windset investment, net of tax, per diluted share | $ | 0.32 | $ | (0.01 | ) | $ | 0.31 | $ | — | |||||||||||
Restructuring and other non-recurring charges, net of tax, per diluted share (1) | $ | 0.15 | $ | 0.07 | $ | 0.43 | $ | 0.07 | ||||||||||||
Adjusted diluted net income (loss) per share | $ | 0.02 | $ | (0.17 | ) | $ | (0.09 | ) | $ | (0.33 | ) |
(Unaudited and in thousands) | Curation Foods | Lifecore | Other | Total | ||||||||||||||||
Three Months Ended November 29, 2020 | ||||||||||||||||||||
Net (loss) income | $ | (12,383 | ) | $ | 4,492 | $ | (5,410 | ) | $ | (13,301 | ) | |||||||||
FMV change in Windset investment | 11,800 | — | — | 11,800 | ||||||||||||||||
Interest expense, net of interest income | 1,376 | — | 1,653 | 3,029 | ||||||||||||||||
Income tax (benefit) expense | (3,911 | ) | 1,419 | (207 | ) | (2,700 | ) | |||||||||||||
Depreciation and amortization | 2,906 | 1,360 | 26 | 4,292 | ||||||||||||||||
Total EBITDA | (212 | ) | 7,271 | (3,938 | ) | 3,120 | ||||||||||||||
Restructuring and other non-recurring charges (1) | 2,591 | — | 2,999 | 5,590 | ||||||||||||||||
Total adjusted EBITDA | $ | 2,379 | $ | 7,271 | $ | (939 | ) | $ | 8,710 | |||||||||||
Six Months Ended November 29, 2020 | ||||||||||||||||||||
Net (loss) income from continuing operations | $ | (20,654 | ) | $ | 4,604 | $ | (8,251 | ) | $ | (24,301 | ) | |||||||||
FMV change in Windset investment | 11,800 | — | — | 11,800 | ||||||||||||||||
Interest expense, net of interest income | 2,751 | — | 3,378 | 6,130 | ||||||||||||||||
Income tax (benefit) expense | (6,523 | ) | 1,454 | (1,940 | ) | (7,009 | ) | |||||||||||||
Depreciation and amortization | 6,316 | 2,669 | 54 | 9,039 | ||||||||||||||||
Total EBITDA | (6,310 | ) | 8,727 | (6,759 | ) | (4,341 | ) | |||||||||||||
Restructuring and other non-recurring charges (1) | 11,055 | — | 5,106 | 16,161 | ||||||||||||||||
Total adjusted EBITDA | $ | 4,745 | $ | 8,727 | $ | (1,653 | ) | $ | 11,820 | |||||||||||
Three Months Ended November 24, 2019 | ||||||||||||||||||||
Net loss | $ | (8,348 | ) | $ | 3,459 | $ | (1,851 | ) | $ | (6,740 | ) | |||||||||
FMV change in Windset investment | (200 | ) | — | — | (200 | ) | ||||||||||||||
Interest expense, net of interest income | 1,364 | — | 780 | 2,144 | ||||||||||||||||
Income tax benefit | (1,723 | ) | 919 | (361 | ) | (1,165 | ) | |||||||||||||
Depreciation and amortization | 3,143 | 1,248 | 23 | 4,414 | ||||||||||||||||
Total EBITDA | (5,764 | ) | 5,626 | (1,409 | ) | (1,547 | ) | |||||||||||||
Restructuring and other non-recurring charges (1) | 1,406 | — | 1,028 | 2,434 | ||||||||||||||||
Total adjusted EBITDA | $ | (4,358 | ) | $ | 5,626 | $ | (381 | ) | $ | 887 | ||||||||||
Six Months Ended November 24, 2019 | ||||||||||||||||||||
Net (loss) income from continuing operations | $ | (10,519 | ) | $ | 2,064 | $ | (3,069 | ) | $ | (11,524 | ) | |||||||||
FMV change in Windset investment | (200 | ) | — | — | (200 | ) | ||||||||||||||
Interest expense, net of interest income | 2,720 | — | 1,474 | 4,194 | ||||||||||||||||
Income tax (benefit) expense | (2,309 | ) | 454 | (675 | ) | (2,530 | ) | |||||||||||||
Depreciation and amortization | 6,348 | 2,433 | 46 | 8,827 | ||||||||||||||||
Total EBITDA | (3,960 | ) | 4,951 | (2,224 | ) | (1,233 | ) | |||||||||||||
Restructuring and other non-recurring charges (1) | 1,406 | — | 1,028 | 2,434 | ||||||||||||||||
Total adjusted EBITDA | $ | (2,554 | ) | $ | 4,951 | $ | (1,196 | ) | $ | 1,201 |
(1) | During fiscal year 2020, the Company announced a restructuring plan to drive enhanced profitability, focus the business on its strategic assets, and redesign the organization to be the appropriate size to compete and thrive. This included a reduction-in-force, a reduction in leased office spaces, and the sale of non-strategic assets. Related to these continued activities, in the second quarter of fiscal 2021, the Company incurred (1) |
Contact Information:
Investor Relations
Jeff Sonnek
(646) 277-1263
jeff.sonnek@icrinc.com
FAQ
What are the key financial results for Landec Corporation in Q2 2021?
How did Landec's adjusted EBITDA change in the second quarter of fiscal 2021?
What is Landec Corporation's guidance for fiscal 2021?
What impacted Landec's net loss in the second quarter of 2021?